Leadership Handover

Leadership Handover

Wolters Kluwer is changing chief executive for the first time since 2003, just as it halves the buyback to fund a step-up in AI reinvestment. The successor, Stacey Caywood, is an insider who ran the division that built the flagship AI product; the CFO stays; the transition ran nine months. The delivery record behind the guidance is strong — 2024 and 2025 both beaten. But the incentive plan itself now targets a lower, high-single-digit earnings bar, and the incoming CEO's own alignment is still nascent.

This chapter is about who now steers the formula, and how they are paid to.

The first handover in twenty-two years

Nancy McKinstry led Wolters Kluwer from September 2003 to February 2026, a tenure of more than twenty-two years across which the company was rebuilt from a print publisher into a software and expert-solutions group [1]. Her successor, Stacey Caywood, becomes CEO and Chair of the Executive Board — the same combined role McKinstry held under the Dutch two-tier structure, where a separate Supervisory Board oversees management [2].

Two features make this less of a break than a first change in over two decades might imply. Caywood is an insider: her in-flight long-term incentive grants were awarded while she was CEO of the Health division [3], the division that houses UpToDate Expert AI — the single most-cited proof point in the AI-durability case (Expert AI). The architect of the flagship AI product is taking the top job. And the transition was deliberate rather than abrupt: Caywood was appointed to the Executive Board at the May 2025 AGM, then led the annual strategic-planning process for the months before taking the helm [4]. CFO Kevin Entricken, in the role since 2013, stays on, holding continuity on the capital-allocation and guidance framework the rest of this report leans on [5].

The timing is what concentrates the risk. The first CEO change in twenty-two years lands in the same year the company halves its buyback to €500m, lifts product-development spend to 12–13% of revenue, and trades at the lowest multiple in its listed history (Buyback Engine). New leadership, a reinvestment pivot, and a derating arrive together.

A record of doing what it said

The reason the 2026 algorithm — margin still rising while product-development spend steps up — carries any credibility is that management has hit its numbers. In both of the last two years it guided conservatively and delivered at or above the top of the range.

Sources: FY2025 guidance from Full-Year 2024 Results [6]; FY2024 guidance from Full-Year 2023 Results [7]; 2025 actuals from the FY2025 Annual Report remuneration report [8].

The pattern is consistent: margin above the guided range both years, free cash flow above the range both years, and adjusted EPS growth ahead of an opening guide that was framed as single-digit. In 2025 the outperformance was formalised — management raised the EPS guidance mid-year before delivering +9% in constant currencies [9]. Against the 2025 short-term-incentive targets, revenue landed at €6,125m against a €6,160m target, adjusted net profit at €1,225m against €1,204m, and adjusted free cash flow at €1,348m against a €1,225m target [10]. Adjusted operating margin has now risen every year from 25.3% in 2021 to 27.5% in 2025 [11]. The caveat that matters: this is the departing CEO's record. The 2026 plan is the first the incoming team owns outright.

Pay that moved with the shares

Management's incentive plan is not a rubber stamp. Over 2023–2025 the long-term plan paid below target across all three measures, and on relative total shareholder return it paid nothing at all: Wolters Kluwer ranked fifteenth of sixteen peers, which under the plan's rules is a zero payout [12]. The earnings and returns legs paid 98% and 77% of target respectively; the share-price leg paid zero [13].

Source: FY2025 Annual Report, Remuneration at a Glance, three-year 2023–2025 total shareholder return chart [14].

The share-price fall reached the executives' own pockets. The CEO's realised pay mix inverted: long-term incentives, weighted at 57% of target pay, delivered only 30% of realised pay once the plan was valued at the lower share price [15]. McKinstry's total 2025 remuneration fell 1.9% to €8.5m and the CEO pay ratio dropped to 66 from 77 [16]. And the alignment runs through personal holdings: McKinstry held 460,412 shares at year-end, worth 26.2 times her base salary, down from 44.2 times a year earlier as the stock fell [17].

Sources: LTIP TSR outcome and rank, FY2025 Annual Report [18]; pay ratio and total pay, Five-Year Overview [19].

The point is not that management is underpaid — €8.5m for the CEO is a large number. It is that the plan actually docked pay when shareholders lost money, which is the property an investor most wants to see and does not always get. The offsetting fact: this alignment is concentrated in the person leaving. Caywood held 18,775 shares at year-end, 1.7 times her base salary, and has five years to reach the required multiple [20]. The twenty-two-year owner-operator's stake walks out the door; the incoming CEO's is still being built.

The incentive plan's new setting

For the 2026–2028 cycle the Supervisory Board reweighted the long-term plan, lifting adjusted EPS to 50% of the award from 30%, holding relative TSR at 30%, and keeping ROIC at 20% [21]. Earnings growth is now the largest single lever in management's own pay. What that lever is set to reward is the notable part.

Source: FY2025 Annual Report — delivered CAGR from the LTIP 2023–2025 outcome [22]; forward targets from the prospective LTIP disclosure [23].

The EPS growth target for 2026–2028 is a compound 9.1% in constant currencies, with the 2025–2027 cycle set at 8.4% [24]. Both sit below the 10.5% the company actually delivered over 2023–2025 [25] and below the roughly 11% adjusted-EPS compounding the decade record established (Compounder Repriced). The pay plan, in other words, formalises the deceleration the 2026 guidance already signalled: Caywood's own outlook is for high-single-digit adjusted-EPS growth while product-development spend rises to 12–13% of revenue and margin still expands [26]. Management is being paid more heavily on an earnings bar it has deliberately lowered. The reweighting cuts the other way too: with the buyback halved, the per-share tailwind that helped clear past EPS targets is smaller, so a 9.1% bar with less buyback support is not obviously softer than a 10% bar with a full one.

Two smaller reads sit alongside. The relative-TSR target is demanding on its own recent form: the plan asks for a position of 5–6 in the peer group [27] against the fifteenth the company just delivered — a high bar that keeps the share-price leg from being easy money. And the governance terms are shareholder-friendly: Caywood and Entricken hold four-year appointments with severance capped at one year's base salary, though a change of control triggers full vesting of conditional share rights — a clause worth noting given the compressed valuation [28]. The remuneration framework itself carries broad owner support: the policy was adopted with more than 95% of votes and the prior year's remuneration report with over 92% [29]. Oversight is being refreshed alongside management: the Supervisory Board has turned over materially, with five of its members appointed in 2022 or later [30].

Where this leaves the reader

On the evidence, the continuity case is the stronger one. The successor is the insider who built the flagship AI product, the CFO stays, the transition ran nine months, the delivery record is real, and the incentive plan demonstrably bites when shareholders lose money. The risks are equally real but narrower: the first leadership change in twenty-two years coincides with the reinvestment pivot and the derating; the departing CEO's large personal stake is not yet matched by the incoming one; and the pay plan now rewards a high-single-digit earnings bar rather than the double-digit compounding the multiple was built on.

What would move the read is a datapoint, not an argument. The half-year results due 5 August 2026 are the first clean print under Caywood, and the test is specific: whether the margin the whole report assumes holds in Tax & Accounting and Health while product-development spend steps up (Margin Ladder), and whether the reallocation from buyback to reinvestment shows up as organic growth rather than only as a lower share count. Delivered, it confirms the algorithm has survived the handover. Missed under new leadership, in the first year the plan is theirs, it would tell the market the formula bent at exactly the point the people running it changed.